Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-24-042178
Filing Date
2024-10-03
Accepted
2024-10-03 17:11:54
Documents
3
Period of Report
2024-10-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1727989907.html 3  
1 FORM 3 wk-form3_1727989907.xml 3 2256
2 EX-24 obyrnejason-section16pow.htm EX-24 4258
3 obyrnejason-section16pow001.jpg GRAPHIC 210335
  Complete submission text file 0001628280-24-042178.txt   297771
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address CARIBOU BIOCIENCES, INC. 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address
O'Byrne Jason (Reporting) CIK: 0001871145 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39083 | Film No.: 241352545